1st Quarter - Report

CEPHALON, INC. for CEPHALON INC

Firm
Client
Income
—
Expenses
$512,334
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Brazilian intellectual property issues

LobbyistCovered position, as disclosed
JENNIFER MICHELE CONNELLY —
JEFF M MYERS —

Contacted: Food & Drug Administration (FDA); Substance Abuse & Mental Health Services Administration (SAMHSA); State, Dept of (DOS); Drug Enforcement Administration (DEA); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); SENATE; Natl Institutes of Health (NIH); Commerce, Dept of (DOC); Federal Trade Commission (FTC); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Alcohol and Drug Abuse ALC

Support for standards for new pharmaceuticals therapies for the treatment of alcoholism. Mental Health Parity

LobbyistCovered position, as disclosed
JEFF M MYERS —

Contacted: Food & Drug Administration (FDA); Federal Trade Commission (FTC); Substance Abuse & Mental Health Services Administration (SAMHSA); Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS); Commerce, Dept of (DOC); Executive Office of the President (EOP); Drug Enforcement Administration (DEA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Natl Institutes of Health (NIH)

Copyright/Patent/Trademark CPT

H.R.2795- Patent Reform Act. Provisions related to pharmaceutical patents; H.R.5418- Establishing a pilot program for patent cases; S.3582- Preserve Access to Affordable Generics Act; H.R.1432-To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market; H.R.2642-Military Construction and Veteran's affairs Appropriations Act 2008.

LobbyistCovered position, as disclosed
JEFF M MYERS —
KIM ZIMMERMAN —

Contacted: SENATE; Substance Abuse & Mental Health Services Administration (SAMHSA); Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Drug Enforcement Administration (DEA); Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS); Food & Drug Administration (FDA); Natl Institutes of Health (NIH); Federal Trade Commission (FTC)

Bills named: H.R. 1432 (110th), H.R. 5418 (110th), H.R. 2642 (110th), H.R. 2795 (110th), S. 3582 (110th)

Health Issues HCR

S.2029 - Physician Payments Sunshine Act of 2007; H.R.5613 - Protecting the Medicaid Safety Net Act; H.R.3610 - Food and Drug Import Safety Act; H.R.4 - Medicare Prescription Drug Price Negotiation Act of 2007; Comparative effectiveness in H.R.3162.

LobbyistCovered position, as disclosed
JENNIFER MICHELE CONNELLY —
JEFF M MYERS —
KIM ZIMMERMAN —

Contacted: Natl Institutes of Health (NIH); State, Dept of (DOS); Federal Trade Commission (FTC); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Drug Enforcement Administration (DEA); Commerce, Dept of (DOC); SENATE; Substance Abuse & Mental Health Services Administration (SAMHSA); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES

Bills named: H.R. 3610 (110th), H.R. 4 (110th), S. 2029 (110th), H.R. 3162 (110th), H.R. 5613 (110th)

Budget/Appropriations BUD

H.Con.Res 95 - Support for additional FDA resources. Support for funds for SAMHSA. FDA funding H.R. 3043 - Labor-HHS Education Appropriations S.Con.Res.70 - Fiscal 2009 Senate Budget Resolution

LobbyistCovered position, as disclosed
JENNIFER MICHELE CONNELLY —
JEFF M MYERS —
KIM ZIMMERMAN —

Contacted: Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; Federal Trade Commission (FTC); Substance Abuse & Mental Health Services Administration (SAMHSA); Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); SENATE; State, Dept of (DOS); Drug Enforcement Administration (DEA)

Bills named: S.Con.Res. 70 (110th), H.Con.Res. 95 (110th), H.R. 3043 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.